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A B S T R A C T
Autism Spectrum Disorders (ASD) are characterized by: social and communication impairments, and by
restricted repetitive behaviors. The aim of the present paper is to review abnormalities of oxytocin (OXT) and
related congenital malformations in ASD. A literature search was conducted in the PubMed database up to 2016
for articles related to the pathomechanism of ASD, abnormalities of OXT and the OXT polymorphism in ASD.
The pathomechanism of ASD has yet to be. The development of ASD is suggested to be related to abnormalities
of the oxytocin-arginin-vasopressin system. Previous results suggest that OXT and arginine vasopressin (AVP)
may play a role in the etiopathogenesis of ASD.
1. Introduction
Autism spectrum disorder was previously perceived as a rare
disorder, but increasing recognition, understanding, and awareness is
changing this perception, and it is now considered to be a relatively
common condition. Prevalence rate estimates vary between 1% and 2%
in school age children (Ben-Ari, 2015).
ASD has a great impact on the quality of life in the aﬀected children
and their family. ASD seems to be a multifactorial disease with the
interaction of genetic and environmental factors. Evidence supporting
the hypothesis that perinatal outcome can play a role in the etiology of
is ASD increasing. The present paper focuses on recent publications
which have demonstrated the role of oxytocin, and prenatal and
perinatal factors associated with an increased risk of ASD (Fakhoury,
2015; Muotri et al., 2016). In this paper, several methodological
advantages have helped to support and extend this hypothesis.
2. Methods
2.1. Search strategy
Published data were used in our paper; therefore, no ethical
approval was required.
The authors searched for the terms ‘ASD’ OR ‘perinatal outcome’
OR ‘oxytocin’ in the following databases: Medline, Pubmed, Scopus,
Index Medicus, and Science Direct.
The following outcome measures were analyzed (1) oxytocin and
oxytocin receptor defect in the development of ASD; (2) the relative
risk of perinatal factors and congenital defects.
• Qualitative data: after screening the title and abstract, all texts not
presenting data on oxytocin-receptor related to ASD were discarded.
• Quantitative data: only papers presenting original work with analy-
sis on the relationship between oxytocin; cesarean section, perinatal
outcome, and development of ASD were included. Reference lists
from these papers were read to search for other possible relevant
papers. Abstracts of scientiﬁc meetings, review papers, anecdotal
case reports, duplicate papers, and editorials were excluded.
3. Results
3.1. The role of oxytocin
Social and communication diﬃculties are the most characteristic
disturbances in ASD, and they are two of the core symptom domains.
Repetitive behavior, and restricted activities and interests constitute
the third domain of symptoms, as listed in the DSM-IV (American
Psychiatric Association, 2000).
Oxytocin (OXT) is a nine-amino-acid peptide that is synthesized in
the paraventricular and supraoptic nucleus of the hypothalamus and
released into the bloodstream by axon terminals in the posterior
pituitary (Lee et al., 2009). The best known eﬀects in women of
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reproductive age are in stimulating uterine contractions during labor
and in regulating lactation. Furthermore, it is important to emphasize
that OXT and the structurally similar peptide AVP are directly released
within the brain, where they play a key role in regulating social
aﬃliative behaviors, including sexual behavior, and social recognition
(Lee et al., 2009; Harony, 2010; Caldwell, 2008). Besides these
functions, the genes coding for the production of OXT and AVP are
located on the same chromosome, 20p13, while the genes for oxytocin
receptor (OXTR) are located on chromosome 3. OXT plays a role in
increasing trust, empathy, eye contact, face memory, and social
interaction (Donaldson and Young, 2008). AVP, which is well known
for its antidiuretic eﬀect, inﬂuences social behavior as well (Harony and
Wagner, 2010). Repetitive behaviors are possibly inﬂuenced by OXT
and AVP since they act as neuromodulators, targeting the hippocam-
pus, amygdala, striatum, hypothalamus, and nucleus accumbens (Insel,
2010; Israel, 2008; Green, 2010). Lastly, it is through their neuromo-
dulatory role that OXT and AVP are implicated in other behaviors such
as stress-response, learning, and memory (Donaldson ZR, 2008).
Overall, they play a critical role in regulating social behavior from the
early phases of development, and thus are likely to be implicated in
ASD unfolding. For more than a decade, several authors and teams
have assessed the possibility that OXT may be inﬂuenced in the social
symptoms of ASD (Insel et al., 2010; Green et al., 2010; Israel et al.,
2008). Abnormalities in OXT/AVP in ASD might be due to diﬀerent
mechanisms, such as a reduction in hormonal levels as a result of
diminished synthesis, an alteration in hormonal release, or insuﬃcient
amounts of these hormones as neuromodulators in the brain possibly
because of receptor abnormalities (Israel et al., 2008; Gregory et al.,
2009). Furthermore, it has been suggested that an alteration in
hormonal release might be secondary to an accelerated synaptic
pruning, and/or alteration of the glia (Wang and Hatton, 2009).
Several neuronal network, neurotransmission and hormone systems
are probably involved in ASD. Currently, neural systems of the
amygdala, the mesocorticolimbic dopamine system and the OXT
system are among the most important ones (Neuhaus et al., 2010).
The relevance of OXT as implicated in the facilitation of social
information processing is possibly obtained through auditory and
visual pathways. Finally, OXT is involved in regulating stress and fear
reactivity, possibly promoting social interaction in individuals with
ASD that often experience anxiety associated with nuclear disturbances
in social interaction (Bartz et al., 2008).
3.2. Genetic studies
Genetic studies also suggested a role of OXT in ASD. The region of
chromosome 3, in which OXTR is located is now considered a
susceptibility locus, as it has repeatedly been found to be implicated
in ASD (Liu et al., 2016; Jansen et al., 2006; Ebstein et al., 2009;
Andari et al., 2010; Green et al., 2001; Guastella et al., 2010; Wang and
Hatton, 2009; Sala et al., 2011; Schmidt et al., 2012; Guastella et al.,
2008; Kurth et al., 2011). Wu et al. have reported an association
between two single nucleotide polymorphisms (SNP) in the OXTR
related to the occurrence of ASD (Wu et al., 2005). Jacob et al. have
also found an association between OXTR and autism; speciﬁcally, a
signiﬁcant association was detected at rs2254298, but in contrast with
Wu et al., not at rs53576 (Jacob, 2007).
Similarly, Lerer et al. have shown that SNPs and haplotypes in the
OXTR gene confer risk for ASD, and in addition, they have observed an
association with IQ and adaptive functions measured with total
Vineland Adaptive Behaviors Scales (communication, daily living skills,
and socialization subdomains) (Lerer et al., 2008). Recently, a study
with a large cohort of 2333 individuals with ASD has demonstrated an
association between three markers implicated in ASD susceptibility,
rs2268493, rs1042778, and rs7632287, further strengthening the
hypothesis that functional polymorphisms of OXTR may contribute
to ASD risk (Campbell et al., 2011). Similar conclusions have been
drawn in another study by Wertmer et al. observing a signiﬁcant
genetic variation in the OXTR gene in patients with ASD including
atypical and high-functioning individuals (Wermter et al., 2010). These
ﬁndings point to an epigenetic dysregulation of OXTR. How this
process might unfold is currently unknown, but it is important to note
that if further evidence is discovered, it might explain the failure to
identify sequence alterations in many candidate genes of ASD, e.g., an
epigenetic alteration would be implicated in ASD phenotype expression
(Gurrieri et al., 2009).
3.3. Perinatal factors
ASD is inﬂuenced by a variety of genetic, environmental, and
possibly immunological factors that act during critical periods to alter
key developmental processes. Some pharmaceutical drugs, toxicants,
and metabolic and nutritional factors have been identiﬁed in epide-
miological studies to increase the risk for autism, especially during the
prenatal period. Immunological risk factors including maternal infec-
tion during pregnancy, autoantibodies to fetal brain proteins, and
familial autoimmune diseases have consistently been observed in
multiple studies, as well as immune abnormalities in individuals with
ASD.
Etiological hypotheses suggest a strong genetic component and a
possible interaction between the epigenetic factors in early fetal
development (Kolevzon et al., 2007).
The suggested environmental factors include nutritional and im-
mune function related risk factors such as lack of vitamin D and folic
acid supplementation, and metabolic syndrome (Gialloreti et al., 2014).
It can be concluded that the rate of cesarean sections was also
signiﬁcantly higher in the case group than in the control group
(Kolevzon et al., 2007; Gialloreti et al., 2014; Curran et al., 2015).
Shieve et al. have concluded that three perinatal risk factors (preterm
birth, small for gestational age, and cesarean section) notably con-
tribute to ASD risk (Shieve et al., 2014). Nilsen et al. (2013) analyzed
clinical data on a large cohort of pregnant women in 2014 concerning
the perinatal outcomes and ASD. The results suggest that cesarean
section, prenatal folic acid use, maternal smoking in the prenatal
period, low birth weight and preterm birth have increased the risk of
developing ASD.
3.4. Congenital anomalies
Earlier population-based register studies on the association be-
tween ASD and syndromes are scanty, as the syndromes are rare (Lee
et al., 2015).
Kielinen et al. have reported a population based study of 187 ASD
children with one Klinefelter syndrome (47, XXY), (0.5%) one 47/XYY
(0.5%, one Down syndrome (0.5%), four Fragile X syndromes (2.1%)
two fetal alcoholic syndrome (1.1%), and one Sotos syndrome (0.5%,
one tuberous sclerosis (0.5%) (Kielinen et al., 2004).
4. Discussion
Considering the complex characteristics of ASD, which are a
combination of biologic heterogeneity and phenotypic heterogeneity,
it is diﬃcult to choose and develop an eﬀective treatment. Since
oxytocin is responsible for not only maternal behavior but also core
symptom domains of ASD, such as social interaction and repetitive
behaviors, association with the pathogenesis of ASD is highly possible.
There are various ongoing animal, human, and clinical studies asses-
sing the potential disruption of oxytocin function or secretion leading
to the etiology of ASD. SNP of the OXTR is the ﬁrst step in the
recognition of new treatment molecules. Through clinical trials apply-
ing oxytocin in patients with ASD, future clinical applications are
promising. Therefore, further research should be carried out to develop
treatment options for children with ASD (Ben-Ari, 2015; Curran et al.,
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